Skip to content

Ketamine as Brief Adjuvant Treatment of Acute Suicidal Ideation in Nonpsychotic Patients

2015 Standard Research Grant
Amount Awarded: $89,644
Focus Area: Clinical Treatment Studies

Cheryl McCullumsmith, M.D., Ph.D.

Cheryl McCullumsmith, M.D., Ph.D.
University of Cincinnati

Inside the Research

Question: Can adding intranasal ketamine serve as a rapid treatment for acute suicidal ideation?

Strategy: Randomly assign people requiring inpatient hospitalization for acute suicidal ideation to receive either intranasal ketamine or saline and follow up after four weeks.

Impact: A short-term treatment specific for acute suicidal ideation that allows for ongoing treatment psychiatric disorders.